Innate Pharma Growth Metrics (2018-2025) | IPHA

Growth Metrics Dec2018 Dec2019 Jun2020 Dec2020 Jun2021 Dec2021 Jun2022 Dec2022 Jun2023 Dec2023 Jun2024 Dec2024 Jun2025
Growth Ratios
EBITDA Margin Growth (1y) 37,536.00-1447.00-31617.00-37736.00-58984.00
EBITDA Margin Growth (3y) 2,998.0018,727.00-1646.00
EBITDA Margin Growth (5y) -36185.00-71874.00
EBIT Margin Growth (1y) 37,536.00-1447.00-31617.00-37736.00-58984.00
EBIT Margin Growth (3y) 2,998.0018,727.00-1646.00
EBIT Margin Growth (5y) -36185.00-71874.00
EBT Margin Growth (1y) 34,236.00-1093.00-29401.00-34940.00-51473.00
EBT Margin Growth (3y) 2,277.009,001.00-1797.00
EBT Margin Growth (5y) -33757.00-71874.00
Enterprise Value Growth (1y) -39.87%-26.69%-86,224.55%25.37%99.88%24.17%27.69%24.47%16.41%3.92%10.14%13.24%17.29%
Enterprise Value Growth (3y) -9.76%10.50%8.18%24.67%90.92%18.06%18.41%14.29%14.67%
Enterprise Value Growth (5y) 5.41%12.25%10.28%18.65%77.65%
FCF Margin Growth (1y) -9241.00-38440.0047,493.00-3398.00-6202.001,052.00
FCF Margin Growth (3y) -188.00126,568.002,851.0042,343.00
FCF Margin Growth (5y) -5338.00
Interest Coverage Ratio Growth (1y) 95,654.20%-99.96%2,994.25%201.69%-28.84%
Interest Coverage Ratio Growth (3y) 1,277.10%-39.75%3.03%
Interest Coverage Ratio Growth (5y) 24.43%36.94%
Net Margin Growth (1y) -5213.00-55736.0094,747.00203.00-11094.00-29401.00-31939.00-51473.00
Net Margin Growth (3y) 33,799.00477,888.0027,918.0051,714.00-80672.00
Net Margin Growth (5y) -9234.00397,014.00
Operating Margin Growth (1y) 37,536.00-1447.00-31617.00-37736.00-58984.00
Operating Margin Growth (3y) 2,998.0018,727.00-1646.00
Operating Margin Growth (5y) -36185.00-71874.00
Return on Assets Growth (1y) -26.00-26.001.0025.0022.00-2.00-14.00-54.00-77.00
Return on Assets Growth (3y) -4.00-3.008.00-31.00-70.00
Return on Assets Growth (5y) -95.00
Return on Capital Employed Growth (1y) -18.00-22.00-11.00-10.00-79.00
Return on Capital Employed Growth (3y) -50.00
Return on Sales Growth (1y) -90.0028.0052.0060.0061.002.00-11.00-294.00-349.00-515.00
Return on Sales Growth (3y) 23.0090.00101.00-232.00-300.00-807.00
Return on Sales Growth (5y) -338.00-719.00